FOXC2 augments tumor propagation and metastasis in osteosarcoma
Metrics: PDF 599 views | HTML 937 views | ?
Maricel C. Gozo1,2,*, Dongyu Jia1,*, Paul-Joseph Aspuria1, Dong-Joo Cheon1, Naoyuki Miura3, Ann E. Walts4, Beth Y. Karlan1,5, Sandra Orsulic1,5
1Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
2Graduate Program in Biomedical Science and Translational Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
3Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan
4Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
5Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
*These authors have contributed equally to this work
Sandra Orsulic, email: email@example.com
Keywords: anoikis, forkhead box C2, osteosarcoma, metastasis, invasion
Received: January 19, 2016 Accepted: September 02, 2016 Published: September 13, 2016
Osteosarcoma is a highly malignant tumor that contains a small subpopulation of tumor-propagating cells (also known as tumor-initiating cells) characterized by drug resistance and high metastatic potential. The molecular mechanism by which tumor-propagating cells promote tumor growth is poorly understood. Here, we report that the transcription factor forkhead box C2 (FOXC2) is frequently expressed in human osteosarcomas and is important in maintaining osteosarcoma cells in a stem-like state. In osteosarcoma cell lines, we show that anoikis conditions stimulate FOXC2 expression. Downregulation of FOXC2 decreases anchorage-independent growth and invasion in vitro and lung metastasis in vivo, while overexpression of FOXC2 increases tumor propagation in vivo. In osteosarcoma cell lines, we demonstrate that high levels of FOXC2 are associated with and required for the expression of osteosarcoma tumor-propagating cell markers. In FOXC2 knockdown cell lines, we show that CXCR4, a downstream target of FOXC2, can restore osteosarcoma cell invasiveness and metastasis to the lung.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.